Fahimeh Ramezani Tehrani: New Findings on Oxidative Stress and PCOS Treatment
Fahimeh Ramezani Tehrani, Professor at Shahid Beheshti University of Medical Sciences, shared a post on LinkedIn about a paper published in Scientific Reports:
“Excited to Share Our Latest Research!
I am pleased to announce that our new article has been published in Scientific Reports:
‘Therapeutic efficacy of Rosa damascena Mill. on oxidative stress parameters and cyclooxygenase-2 gene expression in estradiol valerate-induced polycystic ovarian syndrome in Wistar rats’
DOI: 10.1038/s41598-025-17484-2
What we explored:
- Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age.
- Oxidative stress plays a key role in its pathogenesis.
- We investigated the therapeutic potential of Rosa damascena extract in a rat model of PCOS.
Key findings:
- Higher doses of Rosa damascena extract (800 and 1200 mg/kg/day) significantly improved oxidative stress markers.
- Reactive oxygen species (ROS) levels decreased.
- Cyclooxygenase-2 (Cox2) gene expression was notably reduced.
- The effects were comparable to metformin, a standard treatment.
Why it matters:
Our results highlight the potential of Rosa damascena as a natural therapeutic agent for alleviating PCOS complications, partly through regulating oxidative stress pathways.
I am grateful to my co-authors and collaborators for their contributions to this work. Looking forward to further discussions and future research in this area.”
Title: Therapeutic efficacy of Rosa damascena Mill. on oxidative stress parameters and cyclooxygenase-2 gene expression in estradiol valerate-induced polycystic ovarian syndrome in Wistar rats
Authors: Mahbanoo Farhadi-Azar, Fatemeh Mahboobifard, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Parichehreh Yaghmaei, Fahimeh Ramezani Tehrani
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting
-
Jan 12, 2026, 13:14Lucile Ferreux: Prenatal Cadmium Exposure and Its Long-Term Impact on Male Fertility
-
Jan 12, 2026, 13:11This Month’s Fertility and Sterility Unplugged Is Live – Fertility and Sterility
-
Jan 11, 2026, 10:02Hind Hanani: Understanding the Use of Antiphospholipid Syndrome Guidelines Worldwide
-
Jan 11, 2026, 09:58Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
-
Jan 11, 2026, 09:56Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
-
Jan 11, 2026, 09:52Jamie Agunsday: Understanding Pregnancy-Related Deaths